Specialized heart failure clinics versus primary care: Extended registry-based follow-up of the NorthStar trial.

Morten MalmborgAli Assad Turky Al-KahwaLars KoberChristian Torp-PedersenJawad H ButtDeewa ZahirChristian D TuxenMikael K PoulsenChristian MadelaireEmil FosbolGunnar Hilmar GislasonPer HildebrandtCharlotte AnderssonFinn GustafssonMorten Schou

Published in: PloS one (2023)

HFrEF patients on optimal medical therapy did not benefit from continued follow-up in a specialized HF clinic after initial optimization. Development and implementation of new monitoring strategies are needed.

Keyphrases

primary care
heart failure
end stage renal disease
healthcare
palliative care
ejection fraction
chronic kidney disease
prognostic factors
study protocol
acute heart failure
clinical trial
patient reported
cardiac resynchronization therapy
phase iii
mesenchymal stem cells
bone marrow
stem cells